Farm-matched phage cocktails that let shrimp hatcheries drop antibiotics
TL;DR Shoalguard isolates the Vibrio bacteria killing larvae at each hatchery cluster, matches phages that destroy them, and supplies refreshed cocktails by subscription. Hatcheries and exporter-linked farms pay because antibiotic residues keep getting Indian shrimp shipments refused abroad.
You can't vaccinate a shrimp, so when Vibrio hits a hatchery the habitual fix is antibiotics[1]. That habit now costs exports.
In June 2026 the Drugs Controller General told states that residues caused 43% of 2025 shrimp rejections by the EU, US and Japan, and the US FDA logged 93 residue-linked shrimp refusals that year[2]. MPEDA traced residues to more than 40 farms, 74% of them in Andhra Pradesh[2]. Chloramphenicol and nitrofurans have been banned in food-animal rearing since March 2025, and yet residues still turn up[2].
What it does, in regulatory terms: an antibiotic-free aquaculture input for water and feed, not a drug for humans. It must hold a Coastal Aquaculture Authority certificate of compliance for antibiotic-free inputs before sale[3].
Shoalguard runs a field lab in a hatchery belt. Staff collect samples from tanks and ponds during disease events, isolate the Vibrio strains, and test them against a growing library of phages. The best-matched mix is grown, quality-checked and shipped as a tank additive. Every few months the lab rechecks local strains and updates the cocktail, because bacteria evolve resistance to any fixed mix. Hatcheries also get a disease log that exporters can use as evidence of antibiotic-free rearing.
I reframed the seed. It wanted engineered phage therapy for drug-resistant infections in people, but a 2026 Indian review found only two clinical phage studies in the country and flagged the lack of a regulatory framework[4]. That's years of trials away. Shrimp hatcheries have the same bacterial problem, with faster feedback and a clear approval route.
Hatchery owners pay first, since larval losses hit them within days. Exporters and processors are the second payer - they can fund inputs for contract farms to protect their shipments. I found no public price for phage products in Indian aquaculture. Assume pricing per tonne of tank water per cycle, set against the value of the larvae saved.
The DCGI's June 2026 letter asked state drug controllers for enforcement details[2], so farms using banned drugs face more checks. Indian lab work keeps adding evidence too. A 2025 West Bengal study cut tiger shrimp deaths by 54.76% with a single phage in a challenge test[5]. And a clear CAA route exists for antibiotic-free inputs[3].
No public figure exists for spending on antibiotic alternatives in Indian shrimp farming. The narrowest signal is the cost of rejections - residues behind 43% of 2025 rejections and 93 US refusals[2]. Every exporter facing those refusals is a motivated prospect. Pilot orders from two hatchery clusters would be the first real proof.
One Indian biotech sells two phage products for hatcheries and farms, built on a library of more than 200 phages, and reports 10–15% better larval survival from its own data[1]. Probiotic water additives are sold everywhere as a general alternative.
The gap is local matching and regular cocktail updates, tied to disease records an exporter can actually use.
| Difficulty | Hard (56/100) |
| Starting capital | ₹2–4 Cr |
| Time to launch | 12–18 months |
Isolating phages is routine lab work. Turning them into a reliable product is not, because phages have to stay potent through shipping and storage in coastal heat, and field trials have to show survival gains that farmers believe. Proving it in ponds rather than tanks is harder still.
Yes. You can't sell an aquaculture input here without approval, and that shapes the whole launch plan.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let a model decide what goes into a tank. Phage selection still has to be confirmed in the lab, and survival claims have to come from real hatchery cycles.
Want to work out the AI layer for Shoalguard? Talk to Yash →
This fits a microbiologist who knows aquaculture and doesn't mind living near hatcheries. If you want a human-health biotech story to tell investors then this isn't your idea. Prove one number first - a matched cocktail that lifts larval survival by 10 points across three hatchery cycles, measured by the hatchery itself.
Plan for roughly ₹2–4 Cr over 12–18 months, most of it on the field lab, staff and hatchery trials before the CAA approval lets you sell.
Yes. Antibiotic-free aquaculture inputs need a Coastal Aquaculture Authority certificate of compliance before sale, and you have to handle pathogenic Vibrio under biosafety norms.
Yes, Vibrio is a problem wherever shrimp are farmed. You'd need that country's approval for aquaculture inputs, and the local strains would mean building your phage library from scratch.
The free Shoalguard validation kit has the line-by-line capital breakdown, the effort scoring, the CAA and drug-rule checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for hatcheries and exporters, and 5 assumptions to test. Download the kit →
Thinking about building Shoalguard or something close to it? The make-or-break bit is proving survival gains in real hatchery cycles and not just lab tanks, and I can help you design that proof. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.